Vext Science Future Growth
Future criteria checks 2/6
Vext Science is forecast to grow revenue at 31.3% per annum. EPS is expected to decline by 131.6% per annum.
Key information
n/a
Earnings growth rate
-131.6%
EPS growth rate
Pharmaceuticals earnings growth | 22.9% |
Revenue growth rate | 31.3% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 07 Mar 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 68 | N/A | 13 | 15 | 2 |
12/31/2024 | 48 | N/A | 4 | 8 | 3 |
12/31/2023 | 35 | N/A | 10 | 9 | 3 |
9/30/2023 | 35 | 5 | 4 | 7 | N/A |
6/30/2023 | 34 | 7 | 0 | 5 | N/A |
3/31/2023 | 34 | 8 | -2 | 3 | N/A |
12/31/2022 | 35 | 11 | -3 | 6 | N/A |
9/30/2022 | 37 | 6 | -3 | 8 | N/A |
6/30/2022 | 38 | 6 | 0 | 11 | N/A |
3/31/2022 | 39 | 6 | -10 | 12 | N/A |
12/31/2021 | 37 | 5 | -8 | 11 | N/A |
9/30/2021 | 34 | 5 | -9 | 8 | N/A |
6/30/2021 | 33 | 5 | -8 | 8 | N/A |
3/31/2021 | 30 | 4 | 2 | 6 | N/A |
12/31/2020 | 25 | 2 | -1 | 3 | N/A |
9/30/2020 | 22 | 0 | -2 | 2 | N/A |
6/30/2020 | 20 | 0 | -6 | 1 | N/A |
3/31/2020 | 20 | 0 | -6 | 0 | N/A |
12/31/2019 | 22 | 3 | -6 | 0 | N/A |
9/30/2019 | 23 | 4 | -5 | -1 | N/A |
6/30/2019 | 23 | 5 | -3 | -1 | N/A |
3/31/2019 | 21 | 4 | -1 | 0 | N/A |
12/31/2018 | 18 | 4 | 1 | 2 | N/A |
12/31/2017 | 15 | 4 | 1 | 2 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if VEXT.F's forecast earnings growth is above the savings rate (2.3%).
Earnings vs Market: Insufficient data to determine if VEXT.F's earnings are forecast to grow faster than the US market
High Growth Earnings: Insufficient data to determine if VEXT.F's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: VEXT.F's revenue (31.3% per year) is forecast to grow faster than the US market (8.1% per year).
High Growth Revenue: VEXT.F's revenue (31.3% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if VEXT.F's Return on Equity is forecast to be high in 3 years time